Literature DB >> 35708789

Progressive medial temporal degeneration with TDP-43 pathology is associated with upper limb and bulbar onset types of amyotrophic lateral sclerosis.

Takahiro Takeda1, Sayuri Kokubun2, Yumiko Saito2, Atsuko Tsuneyama2, Ai Ishikawa2, Sagiri Isose2, Kimiko Ito2, Kimihito Arai2, Akihiro Koreki3, Atsuhiko Sugiyama4, Satoshi Kuwabara4, Kazuhiro Honda2.   

Abstract

OBJECTIVE: This study aimed to clarify the relationship between progressive medial temporal atrophy and onset subtype in patients with amyotrophic lateral sclerosis (ALS).
METHODS: Medial temporal atrophy, ALS functional rating scale (ALSFRS), and cognitive function were assessed in 119 patients who were grouped into three ALS subtypes: bulbar, upper limb, and lower limb onset. Medial temporal atrophy, represented by a Z-score, was determined using an analysis software of magnetic resonance images known as the voxel-based specific regional analysis system for Alzheimer's disease (VSRAD). Among 119 patients, 60 underwent follow-up VSRAD, ALSFRS, and cognitive testing. The sequential data were compared among onset subtypes. Furthermore, TDP-43 pathology was assessed in 20 autopsied patients (including seven who underwent VSRAD before death) to examine the relationships among medial temporal atrophy, onset subtypes, and severity of the hippocampal TDP-43 pathology.
RESULTS: Multiple regression analysis revealed that the Z-score at baseline was associated with the age of onset and duration of illness. A high Z-score at baseline and the bulbar/upper limb subtypes affected the progression rate of Z-score. Pathological examination revealed increased hippocampal TDP-43 pathology score associated with bulbar and upper limb subtypes. Moreover, the Z-score before death correlated with the hippocampal TDP-43 pathology score.
CONCLUSION: Medial temporal atrophy in ALS is associated with bulbar and upper limb onset subtypes. This progression may be related to the extent of TDP-43 pathology.
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany.

Entities:  

Keywords:  Amyotrophic lateral sclerosis; Hippocampus; Onset type; TDP-43; Voxel-based specific regional analysis system for Alzheimer’s disease

Mesh:

Substances:

Year:  2022        PMID: 35708789     DOI: 10.1007/s00415-022-11217-5

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   6.682


  25 in total

1.  Prevalence and patterns of cognitive impairment in sporadic ALS.

Authors:  G M Ringholz; S H Appel; M Bradshaw; N A Cooke; D M Mosnik; P E Schulz
Journal:  Neurology       Date:  2005-08-23       Impact factor: 9.910

2.  TDP-43 Pathology Progression Along the Olfactory Pathway as a Possible Substrate for Olfactory Impairment in Amyotrophic Lateral Sclerosis.

Authors:  Takahiro Takeda; Mutsumi Iijima; Toshiki Uchihara; Takashi Ohashi; Danielle Seilhean; Charles Duyckaerts; Shinichiro Uchiyama
Journal:  J Neuropathol Exp Neurol       Date:  2015-06       Impact factor: 3.685

3.  Stages of pTDP-43 pathology in amyotrophic lateral sclerosis.

Authors:  Johannes Brettschneider; Kelly Del Tredici; Jon B Toledo; John L Robinson; David J Irwin; Murray Grossman; EunRan Suh; Vivianna M Van Deerlin; Elisabeth M Wood; Young Baek; Linda Kwong; Edward B Lee; Lauren Elman; Leo McCluskey; Lubin Fang; Simone Feldengut; Albert C Ludolph; Virginia M-Y Lee; Heiko Braak; John Q Trojanowski
Journal:  Ann Neurol       Date:  2013-06-19       Impact factor: 10.422

Review 4.  Amyotrophic Lateral Sclerosis.

Authors:  Robert H Brown; Ammar Al-Chalabi
Journal:  N Engl J Med       Date:  2017-07-13       Impact factor: 91.245

5.  Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis.

Authors:  Manuela Neumann; Deepak M Sampathu; Linda K Kwong; Adam C Truax; Matthew C Micsenyi; Thomas T Chou; Jennifer Bruce; Theresa Schuck; Murray Grossman; Christopher M Clark; Leo F McCluskey; Bruce L Miller; Eliezer Masliah; Ian R Mackenzie; Howard Feldman; Wolfgang Feiden; Hans A Kretzschmar; John Q Trojanowski; Virginia M-Y Lee
Journal:  Science       Date:  2006-10-06       Impact factor: 47.728

6.  TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis.

Authors:  Tetsuaki Arai; Masato Hasegawa; Haruhiko Akiyama; Kenji Ikeda; Takashi Nonaka; Hiroshi Mori; David Mann; Kuniaki Tsuchiya; Mari Yoshida; Yoshio Hashizume; Tatsuro Oda
Journal:  Biochem Biophys Res Commun       Date:  2006-10-30       Impact factor: 3.575

7.  Sporadic amyotrophic lateral sclerosis: two pathological patterns shown by analysis of distribution of TDP-43-immunoreactive neuronal and glial cytoplasmic inclusions.

Authors:  Yasushi Nishihira; Chun-Feng Tan; Osamu Onodera; Yasuko Toyoshima; Mitsunori Yamada; Takashi Morita; Masatoyo Nishizawa; Akiyoshi Kakita; Hitoshi Takahashi
Journal:  Acta Neuropathol       Date:  2008-05-15       Impact factor: 17.088

Review 8.  MRI morphometry in Alzheimer's disease.

Authors:  Hiroshi Matsuda
Journal:  Ageing Res Rev       Date:  2016-01-23       Impact factor: 10.895

9.  Progression of hippocampal degeneration in amyotrophic lateral sclerosis with or without memory impairment: distinction from Alzheimer disease.

Authors:  Takahiro Takeda; Toshiki Uchihara; Nobutaka Arai; Toshio Mizutani; Makoto Iwata
Journal:  Acta Neuropathol       Date:  2008-11-11       Impact factor: 17.088

10.  Risk factors for cognitive impairment in amyotrophic lateral sclerosis: a systematic review and meta-analysis.

Authors:  Tianmi Yang; Yanbing Hou; Chunyu Li; Bei Cao; Yangfan Cheng; Qianqian Wei; Lingyu Zhang; Huifang Shang
Journal:  J Neurol Neurosurg Psychiatry       Date:  2021-02-09       Impact factor: 10.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.